BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11581007)

  • 1. Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging.
    Nelson AE; Mason RS; Robinson BG; Hogan JJ; Martin EA; Ahlström H; Aström G; Larsson T; Jonsson K; Wibell L; Ljunggren O
    Eur J Endocrinol; 2001 Oct; 145(4):469-76. PubMed ID: 11581007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
    Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.
    Nelson AE; Bligh RC; Mirams M; Gill A; Au A; Clarkson A; Jüppner H; Ruff S; Stalley P; Scolyer RA; Robinson BG; Mason RS; Bligh PC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4088-94. PubMed ID: 12970268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oncogenic osteomalacia in a 49-year-old female patient].
    Ludwig J; Mechtersheimer G; Haberkorn U; Nawroth P; Schilling T; Kasperk C
    Dtsch Med Wochenschr; 2005 Feb; 130(5):206-9. PubMed ID: 15678388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia.
    Khadgawat R; Singh Y; Kansara S; Tandon N; Bal C; Seith A; Kotwal P
    Singapore Med J; 2009 Feb; 50(2):e55-7. PubMed ID: 19296011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic osteomalacia.
    McClure J; Smith PS
    J Clin Pathol; 1987 Apr; 40(4):446-53. PubMed ID: 3584490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypophosphatemic oncogenic osteomalacia].
    Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
    Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.
    Wilkins GE; Granleese S; Hegele RG; Holden J; Anderson DW; Bondy GP
    J Clin Endocrinol Metab; 1995 May; 80(5):1628-34. PubMed ID: 7745010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features.
    Clarke BL; Wynne AG; Wilson DM; Fitzpatrick LA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):479-90. PubMed ID: 7586624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic osteomalacia: is there a new phosphate regulating hormone?
    Nelson AE; Robinson BG; Mason RS
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):635-42. PubMed ID: 9497867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan.
    Casari S; Rossi V; Varenna M; Gasparini M; Parafioriti A; Failoni S; Sinigaglia L
    Clin Exp Rheumatol; 2003; 21(4):493-6. PubMed ID: 12942704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral insufficiency fracture of the femoral head and neck in a case of oncogenic osteomalacia.
    Chouhan V; Agrawal K; Vinothkumar TK; Mathesul A
    J Bone Joint Surg Br; 2010 Jul; 92(7):1028-31. PubMed ID: 20595128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic osteomalacia cured by removal of an organized hematoma.
    Colt E; Gopan T; Chong HS
    Endocr Pract; 2005; 11(3):190-3. PubMed ID: 16239206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic osteomalacia from pterygopalatine fossa mass.
    Savage CR; Zimmer LA
    J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor induced osteomalacia.
    Ioakimidis DE; Dendrinos GK; Frangia KB; Babiolakis DN; Chilas GI; Lyberopoulos KL; Kontomerkos TK
    J Rheumatol; 1994 Jun; 21(6):1162-4. PubMed ID: 7932437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive testing in the diagnosis of osteomalacia.
    Bingham CT; Fitzpatrick LA
    Am J Med; 1993 Nov; 95(5):519-23. PubMed ID: 7646591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.